“The health minister suspended measures that would lower the cost for Canadians because the pharmaceutical industry demanded it,” Davies charged.
The letter caused a rift on the Patented Medicine Prices Review Board that ended with the resignation of several board members. Duclos has repeatedly denied putting undue pressure on the independent regulator. The government is still doing consultation on its own pharmacare bill, Duclos confirmed Tuesday, and plans to table it by the end of the year.
While the agreement between the Liberals and the NDP specifically called for the bill to be passed by the end of the year, Duclos said he can’t guarantee that will happen.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: